AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 62 min read$NEOG

Neogen: Fiscal Q1 Earnings Snapshot

Neogen Corp. (NEOG) reported a fiscal Q1 loss of $11.9 million, or 5 cents per share, but adjusted earnings of 8 cents per share, beating analyst estimates. Revenue was $222.8 million, exceeding expectations. The company forecasts full-year revenue between $885M and $890M.

Original reporting
finance.yahoo.com
Published Oct 6, 2026, 8:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 8:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Neogen: Fiscal Q1 Earnings Snapshot — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$NEOGBearishHigh
01

Why it matters

The earnings surprise could trigger short-term volatility, especially in after-hours trading, as investors reassess profit expectations.

02

Market read

First earnings report for the quarter; provides new data for traders and analysts covering the diagnostics sector.

03

What to watch

Guidance range of $885M‑$890M indicates confidence in future growth; cost structure improvements could turn earnings positive next quarter.

Relevance 8/10Novelty 8/10Timing: after-hours

Background

Neogen is a provider of medical testing kits; its earnings release provides fresh guidance and performance metrics.

Company-level read

Ticker impact

$NEOGBearishHigh confidence
Context

Neogen Corp reported Q1 loss of $11.9M and revenue $222.8M, beating estimates and giving full-year guidance.

Expected impact

likely downside as market prices in the loss and modest beat

Evidence & confidence

First report of earnings with surprise loss; investors often react negatively to EPS miss even with revenue beat.

Market effects

Sector

Medical testing sector may see mixed reaction; revenue beat could support peers, but EPS miss may weigh on valuations.

Regional

U.S. biotech/healthcare stocks could see modest pressure in after-hours trading.

Global

Limited to investors tracking US-listed diagnostics companies.

Counterpoint

What could challenge this read

Revenue beat suggests underlying demand strength; the loss may be a temporary accounting issue, offering a buying opportunity.

Key entities

  • Company
    Neogen Corp.

    Medical testing kit manufacturer reporting Q1 results.

Read at source← All news

Also covered by

1 outlet

Related articles

OCT 6
$NEOGMedAI 8/10

What Neogen (NEOG) Said on Its Q1 Earnings Call

Neogen (NEOG) reported Q1 adjusted EBITDA of $41.6M, up 170 bps YoY. Adjusted net income was $17.5M, EPS $0.08. Free cash flow improved by $18M. Debt stood at $774M, cash at $172M. The company raised fiscal 2027 revenue guidance to $885M-$890M and adjusted EBITDA to $181M-$183M. It expects margin improvements post-Petrifilm transition and announced a collaboration with Hinalea. The genomics sale is under regulatory review, with proceeds earmarked for debt reduction.

finance.yahoo.com2 min
OCT 6
$NEOGMedAI 8/10

Compared to Estimates, Neogen (NEOG) Q1 Earnings: A Look at Key Metrics

Neogen (NEOG) reported Q1 revenues across various segments, generally meeting or exceeding estimates. Food Safety revenues grew 7.3% YoY to $163.2M, while Animal Safety revenues increased 4.3% YoY to $59.6M. Some segments saw significant changes, such as Animal Safety Genomics Services, up 211.4% YoY, and Food Safety Genomics Services, down 59.6% YoY.

finance.yahoo.com2 min
OCT 6
$NEOGMed

Neogen’s (NASDAQ:NEOG) Q3 CY2026: Strong Sales, Stock Soars

Neogen (NEOG) reported Q3 CY2026 revenue of $222.8M, beating estimates by 7% and growing 6.5% YoY. Adjusted EPS of $0.08 beat estimates by 50%. The company raised full-year revenue guidance to $887.5M and EBITDA guidance to $182M, both above analyst estimates. Operating margin improved to -0.8% from -7.7% YoY, and free cash flow turned positive at $4.7M.

finance.yahoo.com2 min
OCT 6
$PENGHighAI 8/10

After-Hours Movers: PENG, STZ, NEOG

Penguin Solutions (PENG) rose 3% after reporting strong Q4 results and upbeat FY2027 guidance. Constellation Brands (STZ) fell 5% despite Q2 beat, citing lower FY2027 EPS guidance. Neogen (NEOG) surged 8% on Q1 beat and raised FY2027 revenue outlook. PENG: $1.00 adj. EPS, $567M revenue; STZ: $3.74 EPS, $2.63B revenue; NEOG: $0.08 EPS, $222.8M revenue.

investing.com2 min